Embryonic gene activation in in vitro produced embryos of the domestic cat (Felis catus).
Accurate embryonic gene activation (EGA) is essential for the embryo's developmental potency and reflects the quality of in vitro produced embryos. To describe the dynamic and temporal patterns of EGA in the cat, the mRNA expression of developmentally important genes (DNA methyltransferases 1 and 3A, DNMT1 and DNMT3A; gap junction protein α 1, GJA1; transcription factor octamer 4, POU5F1 (OCT4); insulin-like growth factor (IGF) 1 and 2 receptors, IGF1R and IGF2R) was examined by RT-PCR techniques in preimplantation embryos obtained after in vitro maturation and IVF. Furthermore, influences of ICSI and sperm cryopreservation on the relative mRNA abundance in 4-5-days-old morulae were analyzed. Total RNA was obtained from immature and matured oocytes, 2-cell embryos, 4-cell embryos, and 8-16-cell embryos, morulae, and blastocysts. RNA was transcribed into single-stranded cDNA by reverse transcriptase. After amplification, a nonfelid standard RNA was used for semiquantitative analysis. Our results showed an increase in transcript abundance from the matured oocyte to the 2-cell embryo for all examined genes except for IGF2R, indicating that, in vitro, the embryonic genome is activated shortly after fertilization. However, the activation pattern varied markedly between the different genes. We also found different patterns of mRNA expression for the examined genes in morulae produced either by IVF or ICSI, and using fresh or cryopreserved sperm. Owing to high variations within the single groups of compared morulae, we were able to observe only a tendency toward higher relative mRNA expression in embryos derived by IVF with fresh sperm in comparison to all other groups.
Waurich
R
R
Leibniz-Institute for Zoo and Wildlife Research (IZW), Berlin, Germany. waurich@izw-berlin.de
Ringleb
J
J
Braun
B C
BC
Jewgenow
K
K
D000818:Animals; D001755:Blastocyst / Q000502:physiology*; D002415:Cats / Q000196:embryology*; D017630:Connexins / Q000737:chemistry / Q000235:genetics; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000737:chemistry / Q000235:genetics; D000090205:DNA Methyltransferase 3A; D047108:Embryonic Development / Q000502:physiology*; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000502:physiology*; D008297:Male; D050814:Octamer Transcription Factor-3 / Q000737:chemistry / Q000235:genetics; D011247:Pregnancy; D012313:RNA / Q000737:chemistry / Q000235:genetics; D017526:Receptor, IGF Type 1 / Q000737:chemistry / Q000235:genetics; D017527:Receptor, IGF Type 2 / Q000737:chemistry / Q000235:genetics; D027724:Reproductive Techniques, Assisted / Q000662:veterinary*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary
D017630:Connexins; D050814:Octamer Transcription Factor-3; D017527:Receptor, IGF Type 2; D012313:RNA; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; D017526:Receptor, IGF Type 1